Diabetes Drug Gets FDA Warning Due to Amputation Risk - WebMD

Reuters

Diabetes Drug Gets FDA Warning Due to Amputation Risk WebMD WEDNESDAY, May 17, 2017 (HealthDay News) -- The type 2 diabetes prescription drug canagliflozin (brand names Invokana, Invokamet, Invokamet XR) appears to increase the risk of leg and foot amputations, the U.S. Food and Drug Administration says. FDA warns of foot, leg amputations with J&J diabetes drugReuters Lilly Could Grab Diabetes Share From Dow's J&J On Amputation WoesInvestor's Business Daily FDA Adds Boxed Warning to Janssen's Type 2 Diabetes Drug LabelRegulatory Focus Consumerist -P&T Community -ConsumerAffairs all 40 news articles »